Literature DB >> 8318559

Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.

J Thiele1, H M Kvasnicka, B R Titius, U Parpert, R Nebel, R Zankovich, D Dienemann, H Stein, V Diehl, R Fischer.   

Abstract

To evaluate the prognostic significance of clinical as well as histological disease features at the time of diagnosis, an immunohistochemical and morphometric study was performed on bone marrow trephine biopsies in 130 patients with Ph(1+)-CML. For identification of all cell elements of the megakaryocytopoiesis we used the monoclonal antibody CD61 (Y2/51) and for the macrophages, the recently characterized antibody PG-M1. Density of argyrophilic fibers was determined per fat cell-free marrow area. Based on a multivariate analysis-derived risk model, the reproducibility of the prognostic score described by Sokal and co-workers was tested, particularly with regard to histological variables. Additionally, we calculated the disease-specific loss in life expectancy. Our prognostic model (Cox model) consisted of the variables: age, spleen size, peripheral erythro-normoblasts, pseudo-Gaucher cells, and fiber density. To assess the validity of this new CML score, a receiver-operating curve (ROC) of sensitivity and specificity was constructed. The improved prognostic efficiency of this newly developed risk model in predicting death within 3 years after diagnosis of CML was demonstrated in comparison with generally accepted staging systems. Immunohistochemistry revealed that not the total number of macrophages, but only the subfraction of pseudo-Gaucher cells exerted a significant impact on survival. Furthermore, it was feasible to calculate the number of atypical micromegakaryocytes and pro- and megakaryoblasts. This abnormal and immature cell population showed a significant correlation with fiber density and prognosis. Finally, the practical value of the Hannover classification was tested. This histological classification enabled a discrimination between two groups with different survival patterns, i.e., granulocyte and/or megakaryocyte-rich subtypes versus subtypes with increase in reticulin and collagen fibers.

Entities:  

Mesh:

Year:  1993        PMID: 8318559     DOI: 10.1007/bf01695971

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  53 in total

1.  Peripheral erythroid precursor and prognosis in chronic granulocytic leukemia.

Authors:  A Levis; F Marmont; M A Ciocca Vasino; A Jayme; V Infelise; G Cametti; M Canta; L Resegotti
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

Review 2.  Staging and prognosis in chronic myelogenous leukemia.

Authors:  J E Sokal; M Baccarani; D Russo; S Tura
Journal:  Semin Hematol       Date:  1988-01       Impact factor: 3.851

3.  Myelofibrosis in chronic granulocytic leukemia.

Authors:  H R Gralnick; J Harbor; C Vogel
Journal:  Blood       Date:  1971-02       Impact factor: 22.113

4.  The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens.

Authors:  K C Gatter; J L Cordell; H Turley; A Heryet; N Kieffer; D J Anstee; D Y Mason
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Authors:  B Falini; L Flenghi; S Pileri; M Gambacorta; B Bigerna; H Durkop; F Eitelbach; J Thiele; R Pacini; A Cavaliere
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Platelet PDGF and TGF-β Levels in Myeloproliferative Disorders.

Authors:  M C Martyré
Journal:  Leuk Lymphoma       Date:  1991

8.  Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.

Authors: 
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

9.  Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.

Authors:  M Lazzarino; E Morra; A Castello; D Inverardi; A Coci; G Pagnucco; U Magrini; G Zei; C Bernasconi
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

10.  Morphometric assessment of bone marrow fiber content in acute nonlymphatic leukemia at presentation.

Authors:  I Fohlmeister; H Klein; J Thiele; S Wienhold; R Fischer
Journal:  Anal Quant Cytol Histol       Date:  1988-04       Impact factor: 0.302

View more
  3 in total

1.  Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia.

Authors:  G Büsche; H Majewski; J Schlué; S Delventhal; S Baer-Henney; K F Vykoupil; A Georgii
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

2.  Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.

Authors:  M Nolte; M Werner; M Ewig; R von Wasielewski; H Link; H Diedrich; A Georgii
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

3.  The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.

Authors:  J Thiele; H M Kvasnicka; N Niederle; T K Zirbes; M Schmidt; J Dammasch; B R Meuter; L D Leder; O Kloke; V Diehl
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.